Gene · 1760
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mbnl2 loss alters novel context processing and impairs object recognition memory. | iScience | 2023 | 37216102 | PubTator, text mining | PubMed |
| The TCF4 Trinucleotide Repeat Expansion of Fuchs' Endothelial Corneal Dystrophy: Implications for the Anterior Segment of the Eye. | Invest Ophthalmol Vis Sci | 2023 | 37204786 | PubTator, text mining | PubMed |
| Cumulative effects of weakly repressive regulatory regions in the 3' UTR maintain PD-1 expression homeostasis in mammals. | Commun Biol | 2023 | 37202440 | PubTator, text mining | PubMed |
| Block or degrade? Balancing on- and off-target effects of antisense strategies against transcripts with expanded triplet repeats in DM1. | Mol Ther Nucleic Acids | 2023 | 37200862 | PubTator, text mining | PubMed |
| Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK. | J Ethnopharmacol | 2023 | 37196814 | PubTator, text mining | PubMed |
| TIGD1 Function as a Potential Cuproptosis Regulator Following a Novel Cuproptosis-Related Gene Risk Signature in Colorectal Cancer. | Cancers (Basel) | 2023 | 37190215 | PubTator, text mining | PubMed |
In Vitro Metabolism of 2-Methoxy-N-[3-[4-[3-methyl-4-[(6-methyl- 3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide (CP-724,714) by Aldehyde Oxidase and Predicting Its Percent Contribution Relative to CYP-Mediated Metabolism. | Drug Metab Dispos | 2023 | 37188528 | PubTator, text mining | PubMed |
| Myotonic Dystrophy Type 1 - An Atypical Presentation Having Symmetric Parkinsonism and Early Proximal Muscle Involvement. | Ann Indian Acad Neurol | 2023 | 37179678 | PubTator, text mining | PubMed |
| The evolution of the discrete multirenculate kidney in mammals from ecological and molecular perspectives. | Genome Biol Evol | 2023 | 37159529 | PubTator, text mining | PubMed |
| Myotonic dystrophy type 1 in the COVID-19 era. | Neurol Sci | 2023 | 37155112 | PubTator, text mining | PubMed |
| ONT long-read WGS for variant discovery and orthogonal confirmation of short read WGS derived genetic variants in clinical genetic testing. | Front Genet | 2023 | 37152986 | PubTator, text mining | PubMed |
| Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size. | Int Urol Nephrol | 2023 | 37148486 | PubTator, text mining | PubMed |
| Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia. | Sci Adv | 2023 | 37146135 | PubTator, text mining | PubMed |
| Adolescent anxiety and pain problems: A joint, genome-wide investigation and pathway-based analysis. | PLoS One | 2023 | 37146008 | PubTator, text mining | PubMed |
| Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1. | Brain | 2023 | 37143315 | PubTator, text mining | PubMed |
| METTL7A (TMT1A) and METTL7B (TMT1B) Are Responsible for Alkyl S-Thiol Methyl Transferase Activity in Liver. | Drug Metab Dispos | 2023 | 37137720 | PubTator, text mining | PubMed |
| Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors. | J Med Chem | 2023 | 37134237 | PubTator, text mining | PubMed |
| Parent-of-Origin Effect on the Age at Symptom Onset in Myotonic Dystrophy Type 2. | Neurol Genet | 2023 | 37123986 | PubTator, text mining | PubMed |
| BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice. | Pharmaceutics | 2023 | 37111604 | PubTator, text mining | PubMed |
| The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future. | Int J Mol Sci | 2023 | 37108647 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1760/papers?page=16